- Info
- Portfolio
- Significant Ownership
- Insider Ownership
Significant Ownership of Opaleye Management Inc.
- Signature - Title
- /s/ James Silverman - President
- Location
- Boston, MA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Opaleye Management Inc..
Follow Filing Activity
Follow Opaleye Management Inc. and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Opaleye Management Inc.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SLGL | Sol-Gel Technologies Ltd | Ordinary Shares, par value NIS 1.00 per share. | 17% | $41,038,865 | +$8,288,097 | 460,335 | +25% | Opaleye Management Inc. | 13 Feb 2026 |
| ACOG | Alpha Cognition Inc. | Common Stock, no par value | 11% | $12,182,054 | +$612,250 | 2,388,638 | +5.3% | Opaleye Management Inc. | 02 Mar 2026 |
| KPTI | Karyopharm Therapeutics Inc. | Common Stock, no par value | 9.5% | $10,262,842 | 1,569,002 | Opaleye Management Inc. | 10 Oct 2025 | ||
| QTTB | Q32 Bio Inc. | Common Stock, par value $0.0001 per share | 8.6% | $4,936,976 | 1,256,228 | Opaleye Management Inc. | 19 Feb 2026 | ||
| IBIO | iBio, Inc. | Common Stock, par value $0.001 per share | 7.6% | $787,500 | 750,000 | Opaleye Management, Inc. | 31 Dec 2024 | ||
| CDXS | Codexis, Inc. | Common Stock, par value $0.0001 per share | 7.5% | $11,067,273 | -$3,583,149 | 6,789,738 | -24% | Opaleye Management Inc. | 31 Dec 2025 |
| RZLT | Rezolute, Inc. | Common Stock | 5.3% | $46,967,324 | 4,912,900 | Opaleye Management Inc. | 12 Dec 2025 | ||
| LRMR | Larimar Therapeutics, Inc. | Common Stock | 4.8% | $15,412,500 | +$590,966 | 4,110,000 | +4% | Opaleye Management, Inc. | 29 Aug 2025 |
| TARA | Protara Therapeutics, Inc. | Common Stock | 4.7% | $7,473,600 | -$410,400 | 1,730,000 | -5.2% | Opaleye Management, Inc. | 31 Mar 2025 |
| OCUL | OCULAR THERAPEUTIX, INC | Common Stock, par value $0.0001 per share | 2.8% | $34,305,750 | 4,342,500 | Opaleye Management Inc. | 31 Dec 2024 | ||
| CNTX | Context Therapeutics Inc. | Common Stock, par value $0.001 per share | 0% | $0 | 0 | Opaleye Management Inc. | 31 Dec 2024 |
Schedules 13D/G Reported by Opaleye Management Inc.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.